Assembly Biosciences (NASDAQ:ASMB) Lifted to Hold at StockNews.comTicker Report • 24 days ago
StockNews.com upgraded shares of Assembly Biosciences (NASDAQ:ASMB - Free Report) from a sell rating to a hold rating in a research report released on Friday. Separately, HC Wainwright reiterated a...
Share to Feed
Assembly Biosciences (NASDAQ:ASMB - Get Free Report) was upgraded by StockNews.com from a "sell" rating to a "hold" rating in a research note issued to investors on Friday.
Separately, HC Wainwright...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Assembly Biosciences (ASMB Research Report), Nater...
Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) Director John G. Mchutchison sold 1,206 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of...
In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Assembly Biosciences (ASMB Research Report). The company's s...
StockNews.com downgraded shares of Assembly Biosciences (NASDAQ:ASMB - Free Report) from a hold rating to a sell rating in a research note released on Thursday morning. Assembly Biosciences Stock...
Assembly Biosciences (NASDAQ:ASMB - Get Free Report) was downgraded by investment analysts at StockNews.com from a "hold" rating to a "sell" rating in a note issued to investors on Thursday.
Assembly...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
The post...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Four candidates planned to be in clinical development in 2024 with interim data from two studies anticipated by year end Clinical development timelines accelerated for ABI-5366; now anticipating...